Demystifying Elanco Animal Health: Insights From 4 Analyst Reviews
Portfolio Pulse from Benzinga Insights
Elanco Animal Health (NYSE:ELAN) received mixed analyst ratings over the past three months, with a decrease in average price target from $19.75 to $18.00. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Despite a 12.02% revenue growth, Elanco faces challenges with profitability and financial returns.
September 19, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Elanco Animal Health has received mixed analyst ratings, with a decrease in the average price target from $19.75 to $18.00. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Despite a 12.02% revenue growth, Elanco faces challenges with profitability and financial returns.
The mixed analyst ratings and the decrease in average price target suggest a neutral short-term impact on Elanco's stock price. While the company has shown revenue growth, its profitability challenges and lower financial returns may offset positive sentiment. The adjustments in ratings and price targets by analysts indicate a cautious outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100